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Lactobacilli are involved in the microbial homeostasis in the female genital tract. Due
to the high prevalence of many bacterial diseases of the female genital tract and
the resistance of microorganisms to various antimicrobial agents, alternative means
to control these infections are necessary. Thus, this study aimed to evaluate the
probiotic properties of well-characterized Lactobacillus species, including L. acidophilus
(ATCC 4356), L. brevis (ATCC 367), L. delbrueckii ssp. delbrueckii (ATCC 9645),
L. fermentum (ATCC 23271), L. paracasei (ATCC 335), L. plantarum (ATCC 8014),
and L. rhamnosus (ATCC 9595), against Candida albicans (ATCC 18804), Neisseria
gonorrhoeae (ATCC 9826), and Streptococcus agalactiae (ATCC 13813). The probiotic
potential was investigated by using the following criteria: (i) adhesion to host epithelial
cells and mucus, (ii) biofilm formation, (iii) co-aggregation with bacterial pathogens, (iv)
inhibition of pathogen adhesion to mucus and HeLa cells, and (v) antimicrobial activity.
Tested lactobacilli adhered to mucin, co-aggregated with all genital microorganisms, and
displayed antimicrobial activity. With the exception of L. acidophilus and L. paracasei,
they adhered to HeLa cells. However, only L. fermentum produced a moderate
biofilm and a higher level of co-aggregation and mucin binding. The displacement
assay demonstrated that all Lactobacillus strains inhibit C. albicans binding to mucin
(p < 0.001), likely due to the production of substances with antimicrobial activity.
Clinical isolates belonging to the most common Candida species associated to
vaginal candidiasis were inhibited by L. fermentum. Collectively, our data suggest that
L. fermentum ATCC 23271 is a potential probiotic candidate, particularly to complement
candidiasis treatment, since presented with the best probiotic profile in comparison with
the other tested lactobacilli strains.
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INTRODUCTION
The microbiota of the female genital tract is composed of diverse aerobic, anaerobic, and
microaerophilic microorganisms (Ravel et al., 2011). The genus Lactobacillus is considered a
biological marker of the normal vaginal microbiota (Lidbeck and Nord, 1993; Witkin et al., 2007).
The majority of reproductive-aged women carry 107–109 Lactobacillus/g of vaginal secretion
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(Ferris et al., 2007; Zhou et al., 2007). Lactobacilli display several
defense mechanisms against pathogens, such as the production of
antimicrobial components and adhesion to the mucosa to create
a barrier that inhibits pathogen colonization by competing for
binding sites on epithelial cells (Walencka et al., 2008; Medellin-
Pena and Griffiths, 2009; Nami et al., 2014; Gorska et al., 2016).
Several factors or conditions can alter the balance of the genital
tract microbiota, including inadequate or prolonged antibiotic
therapy, tight or synthetic-fiber clothing and an acidic diet.
Such conditions facilitate the excessive growth of aerobic and
anaerobic microorganisms in the genital tract, leading to the
development of two clinical syndromes, vaginitis and vaginosis,
which are very common among females (Ravel et al., 2011).
Vaginitis is characterized by the presence of inflammation and
discharge, which are triggered by the proliferation of some
pathogens, especially Candida albicans, amongst others (Donders
et al., 2002; Lobos et al., 2013; Wang et al., 2016).
In addition to these microorganisms, several agents of sexually
transmitted diseases (STDs) represent a serious public health
burden due to their high morbidity rates. For example, infections
due to Neisseria gonorrhoeae are among the most prevalent
STDs. The World Health Organization reports 106 million
gonorrhea new cases annually. Gonococcal infections that are
not adequately treated may cause permanent damage to the
female reproductive tract, resulting in ectopic pregnancy or even
infertility (WHO, 2012).
Other microorganisms, such as Streptococcus agalactiae,
colonize the female genital tract as commensals of the vagina, but
can be transmitted to newborns during delivery (Hansen et al.,
2004), leading to neonatal infection and meningitis (Puopolo
et al., 2005). Although antibiotic prophylaxis has decreased the
incidence of these infections, case reports of disease caused
by S. agalactiae continue to occur in infants with significant
morbidity and mortality (Puopolo et al., 2005). Therefore, new
alternative approaches are needed, since the current methods to
prevent genital infections are not always effective against those
caused by primary pathogens or commensal microorganisms
transmitted during birth.
Bacterial adhesion to the mucosa and epithelial cell surface is a
key event in the colonization of the host and disease progression.
Understanding the adhesion strategies used by pathogens in
order to colonize the host is crucial for the development
of preventive or therapeutic interventions against infectious
diseases. One approach is the use of non-pathogenic bacteria that
are natural components of the microbiota and that can potentially
inhibit the adhesion and establishment of pathogenic bacteria
(Spurbeck and Arvidson, 2010).
Members of the Lactobacillus genus have been proposed as
probiotics as they can protect against infectious disease agents (Li
et al., 2012; Ren et al., 2012; Zabihollahi et al., 2012; Alexandre
et al., 2014). From those, some (L. crispatus and L. acidophilus)
commonly colonize the female genital tract and have been studied
as probiotics (Mastromarino et al., 2002; Antonio et al., 2009;
Zhang et al., 2012; Kaewnopparat et al., 2013; Nami et al.,
2014; Verdenelli et al., 2014). However, it is not known whether
Lactobacillus species that are less frequent in the vagina also
display probiotic activities. Here, we evaluated the probiotic
potential of several reference species of the Lactobacillus genus
not usually found in the vaginal microbiome against three
important microorganisms associated with genital infections,
neonatal sepsis, and meningitis.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The following Lactobacillus reference strains were used: L. brevis
(ATCC 367), L. delbrueckii ssp. delbrueckii (ATCC 9645),
L. fermentum (ATCC 23271), L. paracasei (ATCC 335),
L. plantarum (ATCC 8014), and L. rhamnosus (ATCC 9595).
For comparison, a reference strain of Lactobacillus acidophilus
(ATCC 4356) was included in the study as a representative species
of the female genital tract. All strains were routinely grown in
Man, Rogosa, and Sharpe (MRS) broth or agar (Difco, USA) and
incubated in an anaerobic atmosphere (Probac, Brazil) at 37◦C
for 24 h. The pathogens evaluated were: (i) C. albicans (ATCC
18804), which was grown on Sabouraud dextrose agar (Difco,
USA) at 37◦C for 24 h; (ii) N. gonorrhoeae (ATCC 9826), which
was cultured on gonococci (GC) agar (Difco, USA) supplemented
with VX supplement (LaborClin, Brazil) and hemoglobin (Difco,
USA) at 37◦C for 48 h under a 5% CO2 atmosphere; and (iii)
S. agalactiae (ATCC 13813), which was cultivated on Columbia
agar (Difco, USA) supplemented with 5% sheep blood, under 5%
CO2 at 37◦C for 24 h. All strains were obtained from the Culture
Collection Laboratory of the Fundação Instituto Oswaldo Cruz
(Rio de Janeiro, Brazil) and stored in Brain Heart Infusion (BHI)
broth (Difco, USA) with 20% glycerol (Amresco, Australia) at
−86◦C. Clinical isolates of Candida spp. were kindly donated by
Dr. Cristina A. Monteiro from the Universidade CEUMA.
HeLa Cell Culture
Human cervical epithelial (HeLa) cells were cultured in
Dulbecco’s Modified Eagle’s Medium (DMEM) containing
GlutaMAX (GibcoTM, USA) and supplemented with 1×
antibiotic-antimycotic solution (Gibco, USA) and 10% fetal
bovine serum (Gibco, USA) at 37◦C under a 5% CO2 atmosphere.
Adhesion Assays to Eukaryotic Cells
Prior to the adhesion assays, Lactobacillus strains were cultured in
MRS broth under the conditions described above. After 24 h, the
bacterial cultures were centrifuged at 6,000× g and washed three
times with phosphate-buffered saline (PBS, pH 7.4, Sigma, USA)
in order to remove organic acids produced during growth. The
pellets were resuspended in 300µl of DMEM. The adhesion assay
was performed as previously described (Kaewnopparat et al.,
2013), with minor modifications. Briefly, HeLa cell monolayers
were seeded into 24-well plates with or without glass coverslips
and allowed to grow to 80–90% confluence. Fifty microliters
(∼2.3 × 107) of the bacterial suspensions were added to each
well, and the plates were incubated at 37◦C under 5% CO2
for 3 h. Then, each well was washed three times with PBS for
removal of non-adherent bacteria. Immediately after, the cells
were incubated with 0.1% Triton X-100 (Sigma, USA) for 5 min,
and 10-fold serial dilutions were spread onto agar plates for
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quantification of the total number of bacteria adhered to the
cells (in colony forming unit; CFU). To visualize the bacterial
adherence to HeLa cells, each glass coverslip was fixed with
methanol (P.A., Amresco, Australia) and stained with 0.2% May-
Grunwald and 0.6% Giemsa (Amresco, Australia). The coverslips
were then mounted onto glass slides and visualized by light
microscopy under oil-immersion objective 100× (Leica ICC50
HD microscope). HeLa cells incubated in the absence of bacteria
were used as negative controls.
Biofilm Formation by Lactobacillus spp.
Biofilm formation on a polystyrene surface was quantified in
96-well plates as described by Stepanovic et al. (2000). Briefly,
Lactobacillus spp. were cultured for 24 h and then adjusted
to an optical density of 0.7 at 540 nm. Then, 200 µl of the
bacterial suspensions were added into the wells. Wells containing
MRS broth only were used as negative controls. The plates were
incubated at 37◦C for 24 h, washed three times with 300µl of PBS
(pH 7.4) and air-dried. Each well was then fixed with 200 µl of
methanol (P.A., Amresco, Australia) and the plate was incubated
at room temperature for 15 min. Following, the methanol
was discarded, and the microplate was air-dried. Two hundred
microliters of 2% crystal violet (Amresco, Australia) was added
to each well and incubated for 15 min. The plate was then washed
three times with distilled water and air-dried. To extract the dye
impregnated in the biofilm, 160 µl of 33% glacial acetic acid
(Amresco, Australia) were added per well. The absorbance was
immediately measured at 540 nm using an ELISA plate reader
(Bio-Tek Instrument Co., WA, USA) and taken as indicative of
biofilm formation. Based on the optical densities of the isolates
(OD) and the negative controls (ODC), the biofilm formation
by Lactobacillus was classified as follows: 1, non-adherent:
OD ≤ ODC; 2, weakly adherent: ODC < OD ≤ (2 × ODC); 3,
moderately adherent: (2×ODC)<OD≤ (4×ODC); 4, strongly
adherent: (4× ODC) < OD.
Hydrophobicity of Lactobacillus spp. Cell
Surface
The hydrophobicity of Lactobacillus cell surface was evaluated
using the salt aggregation assay (Andreu et al., 1995). For
this, bacteria were resuspended in 0.02 M sodium phosphate
(pH 6.8). Bacterial suspensions (∼1.2 × 109 CFU/ml) were
mixed (1:1, v/v) with different concentrations of ammonium
sulfate (0.5–4.0 M; Amresco, Australia) on a glass slide. The
lowest final concentration of ammonium sulfate able to promote
aggregation of Lactobacillus was defined as the salt aggregation
value. Hydrophobicity was classified as high, intermediate, or
hydrophilic at salt aggregation values of <0.9 , 0.9–1.5, and
>1.5 M, respectively. For comparison, a solution of 0.02 M
sodium phosphate (pH 6.8) without bacteria was used as negative
control.
Binding of Lactobacillus spp. and Genital
Pathogens to Mucin
The ability of the pathogen and Lactobacillus strains to adhere
to mucin was evaluated as previously described (Tallon et al.,
2007), with minor modifications. Initially, porcine gastric mucin-
type III (Sigma, Saint-Quentin-Fallavier, France) was solubilized
in PBS (Sigma, USA; pH 7.4) at a final concentration of 10 mg/ml.
Five hundred microliters of mucin solution were added into a 24-
well plate and allowed to bind to the wells for 16 h at 4◦C. The
mucin solution was removed; the wells were washed three times
with 1 ml of PBS, saturated with 2% bovine serum albumin for
4 h at 4◦C, and washed four times with PBS. Bacterial cultures
were centrifuged at 6,000 × g for 5 min, washed three times
with PBS, and resuspended in the same buffer to an optical
density of 0.1 at 600 nm (∼4.5 × 107 CFU/ml for lactobacilli
and ∼1.5 × 108 CFU/ml for pathogen strains). Next, 500 µl
of each bacterial suspension were added to the wells, and the
plate was incubated at 37◦C for 1 h. After incubation, the wells
were washed three times with 1 ml of PBS to remove unbound
bacteria. In order to quantify the number of bound bacteria,
each well was treated with 1 ml of 0.5% Triton X-100, and the
plates were incubated for 30 min at room temperature under
agitation. Aliquots (100 µl) were taken from each well, and 10-
fold serial dilutions were prepared and spread onto agar plates for
quantification of the total number of bacteria adhered to mucin
(in CFU). For all experiments, the purity of the bacterial colonies
was checked both macroscopically (by the growth aspects) and
microscopically (by the Gram stain). Mucin-containing wells
without bacteria were used as negative controls.
Exclusion and Displacement Inhibition
Assays
After determining which organisms are able to adhere to mucin,
we performed both exclusion and displacement inhibition assays.
For this, Lactobacillus spp. (∼4.5× 107 CFU/ml) were inoculated
either 1 h prior (exclusion assay) or after (displacement assay)
the tested pathogens (∼1.5 × 108 CFU/ml) (Tallon et al., 2007).
Quantification of Lactobacillus and genital pathogens was carried
out as described above (see Binding of Lactobacillus spp. and
Genital Pathogens to Mucin). Mucin-containing wells without
bacteria were used as negative controls.
Co-aggregation of Lactobacillus spp.
with Genital Pathogens
This assay was performed to determine whether the lactobacilli
are able to co-aggregate with the tested genital pathogens. The
lactobacilli and pathogen suspensions (in PBS) were adjusted
to achieve turbidity equivalent to that of McFarland’s No. 4
standard (∼1.2 × 109 CFU/ml). Five hundred microliters of
each Lactobacillus were added per well and mixed with 500 µl
of each pathogen suspension into 24-well plates. The plates
were then incubated at 37◦C for 4 h under constant agitation
(100 rpm) in an orbital shaker. The microbial suspension of
each well was evaluated under an inverted light microscope
and a score was attributed as described by Reid et al. (1990):
0= no aggregation, 1= small aggregates comprising small visible
clusters of bacteria, 2= aggregates comprising larger numbers of
bacteria, settling to the center of the well, 3 = macroscopically
visible clumps comprising larger groups of bacteria which settle
to the center of the well, 4 = maximum score allocated to
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describe a large, macroscopically visible clump in the center of
the well. The aggregates were visualized using an inverted light
microscope with a 16× magnification lens. Accordingly, results
were expressed as aggregation score.
Antimicrobial Activity of Lactobacillus
spp. against Genital Pathogens
The antimicrobial actions of Lactobacillus spp. against
genital pathogens were assessed as previously described by
Mastromarino et al. (2002) with minor modifications. For this,
10 µl (∼107 CFU/ml) of Lactobacillus spp. suspensions were
spotted onto MRS agar, and bacteria were allowed to grow for
24 h at 37◦C, under anaerobiosis. In a typical assay, three to
four distinct suspensions of Lactobacillus strains were spotted
onto a 90 mm-diameter plate. After incubation, 10 ml of the
specific culture medium for each pathogen was cooled to 50◦C
and poured onto the plate. Pathogen suspensions were adjusted
to achieve turbidity equivalent to that of McFarland’s No. 0.5
standard (∼1.5 × 108 CFU/ml, for bacterial pathogens and
1–5 × 106 CFU/ml, for C. albicans). Pathogens were then spread
separately onto agar plates and incubated for 24 or 48 h at 37◦C
under aerobic or 5% CO2 culture conditions, depending on the
microorganism. Antimicrobial activities were characterized by
the diameter (in millimeter) of the zone of growth inhibition
directly above the Lactobacillus growth area.
Statistical Analysis
GraphPad Prism (version 5.0; GraphPad Software, Inc. San
Diego, CA, USA) software was employed for statistical analysis.
For the mucin adhesion and inhibition assays, the Shapiro–
Wilk normal test and analysis of variance (ANOVA) test were
employed. The Dunnett’s test was employed to compare different
groups of microorganisms with respect to the control. Statistical
significance was established at p < 0.05. All assays were
performed in triplicate on three independent days.
RESULTS
Adhesion Ability of Lactobacillus spp. to
HeLa Cells
We investigated the ability of Lactobacillus spp. to adhere to
human epithelial (HeLa) cells. Amongst the tested Lactobacillus,
L. brevis ATCC 367, L. delbrueckii ssp. delbrueckii ATCC 9645,
L. fermentum ATCC 23271, L. plantarum ATCC 8014, and
L. rhamnosus ATCC 9595 displayed the highest levels of adhesion
to epithelial cells, as denoted by the number of bacteria adhered
to the cells, which ranged from 107 to 108 CFU/ml (Figure 1). On
the other hand, L. acidophilus ATCC 4356 and L. paracasei ATCC
335 presented the lowest capacity to adhere to HeLa cells, with a
recovery of less than 103 CFU/ml from the cell surface.
Hydrophobicity of Lactobacillus spp. Cell
Surface and Biofilm Formation
Overall, none of the tested lactobacilli were great biofilm
producers with only L. fermentum presenting a moderate ability
FIGURE 1 | Quantification of the adhesion of Lactobacillus
(∼2.3 × 106 CFU) strains to HeLa cells. The values are expressed in
CFU/ml and represent the means of the values obtained. The assay was
performed in triplicate.
to form biofilm on a plastic surface (Table 1). L. acidophilus was
unable to form biofilm under the used experimental settings.
Also, with the exception of L. acidophilus, all strains exhibited
high cell surface hydrophobicity (Table 1).
Binding of Lactobacillus spp. and Genital
Pathogens to Mucin
All tested microorganisms presented similar ability to bind to
mucin, as the number of cells recovered at the end of the assay
was greater than 104 CFU/ml for both the lactobacilli and the
genital pathogens (Figure 2). Interestingly, L. fermentum binding
to mucin was twofold higher than that observed for the remaining
Lactobacillus strains. When evaluated in an exclusion assay in the
TABLE 1 | Biofilm formation and hydrophobicity of Lactobacillus spp. cell
surface.
Lactobacillus species Biofilm∗ Hydrophobicity∗∗
L. acidophilus Non-adherent Hydrophilic
L. brevis Weakly adherent High
L. delbrueckii ssp. delbrueckii Weakly adherent High
L. fermentum Moderately adherent High
L. paracasei Weakly adherent High
L. plantarum Weakly adherent High
L. rhamnosus Weakly adherent High
∗After measuring the optical densities of the isolates (OD) and the negative
control (ODC), the biofilms were classified as: 1, non-adherent: OD ≤ ODC;
2, weakly adherent: ODC < OD ≤ (2 × ODC); 3, moderately adherent:
(2 × ODC) < OD ≤ (4 × ODC); 4, strongly adherent: (4 × ODC) < OD. The
assays were performed in triplicate. ∗∗Lactobacillus hydrophobicity was classified
as high, intermediate, or hydrophilic at salt aggregation values of <0.9, 0.9–1.5,
and >1.5 M, respectively.
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FIGURE 2 | Quantification of mucin adhesion by Lactobacillus spp.
(∼4.5 × 107 CFU/ml) and genital pathogens (∼1.5 × 108 CFU/ml). The
values are expressed in CFU/ml and represent the means of the values
obtained. The assay was performed in triplicate.
presence of genital pathogens, both L. brevis and L. delbrueckii
ssp. delbrueckii significantly increased (twofold) C. albicans
binding to mucin in comparison to the pathogen binding in
the absence of lactobacilli (p < 0.05; Figure 3A). Similarly,
all lactobacilli (excepting L. plantarum) enhanced S. agalactiae
binding to mucin (three- to sixfold increase) (Figure 3B).
No effects were observed for any of the tested lactobacilli on
N. gonorrhoeae binding (p = 0.42; Figure 3C). Assessment of
lactobacilli effects on pathogen binding in a displacement assay
demonstrated that C. albicans binding to mucin is markedly
inhibited (∼80% inhibition; p< 0.001) by all tested Lactobacillus
spp. (Figure 4A). None of the evaluated lactobacilli affected
S. agalactiae and N. gonorrhoeae ability to bind to mucin (p= 0.51
and p= 0.36, respectively; Figures 4B,C).
Co-aggregation of Lactobacillus spp.
with Genital Pathogens
A co-aggregation assay was performed to evaluate whether
Lactobacillus strains interact directly with genital pathogens. All
lactobacilli co-aggregated with the tested genital pathogens, with
distinct levels of interaction (Table 2). The highest co-aggregation
score was observed for L. fermentum, which was able to interact
with all pathogens, in especial C. albicans (score= 4). L. paracasei
exhibited a high ability to co-aggregate with both S. agalactiae
(score = 4) and N. gonorrhoeae (score = 3), but a low degree of
co-aggregation with C. albicans (score= 1). Overall, Lactobacillus
strains presented a low ability to interact with S. agalactiae
(score = 1); excepting L. fermentum (score = 3) and L. paracasei
(score = 4) to which it was observed a greater capacity to co-
aggregate with this pathogen in comparison with the other tested
lactobacilli.
Antimicrobial Activity of Lactobacillus
Strains against Genital Pathogens
We next assessed whether Lactobacillus spp. possess
antimicrobial activity against genital pathogens. All lactobacilli
inhibited pathogen growth, presenting inhibition zones ranging
from 9.0 ± 0.8 to 19.6 ± 0.4 mm of diameter (Table 3;
Supplementary Figures S1A–F). L. rhamnosus only reduced
the growth of C. albicans in the area immediately above
Lactobacillus growth, without producing a large inhibition zone
(Supplementary Figure S1B). A similar activity was observed for
L. delbrueckii ssp. delbrueckii when tested against S. agalactiae
and N. gonorrhoeae (Supplementary Figures S1C,E).
Antimicrobial Activity of L. fermentum
against Clinical Isolates of Candida spp.
As L. fermentum ATCC 23271 was the one that presented the
greatest ability to form biofilm on surfaces, and the one that
presented the greatest ability to co-aggregate with all tested
pathogens, especially C. albicans, we carried out additional
experiments in order to evaluate the antimicrobial effects of
L. fermentum on clinical strains of Candida spp. Seven isolates
of five species were tested in the same overlay inhibition assay
and included C. albicans (two strains), C. glabrata (two strains),
C. parapsilosis (one strain), C. tropicalis (one strain), and C. krusei
(one strain). With the exception of C. krusei, all the remaining
clinical strains had their growth inhibited by L. fermentum.
A large inhibition zone was observed for one of the C. albicans
isolates (18 mm), whereas the growth of the other Candida
isolates were inhibited only in the area immediately above the
Lactobacillus growth zone (Table 4).
DISCUSSION
Herein, we presented novel evidence on that Lactobacillus species
that are less frequent in the female genital tract are potential
probiotics. Although L. fermentum was not the best in terms of
adhesion to HeLa cells and presented with similar effects to those
of the other tested lactobacilli in regards of the exclusion and
displacement assays, this bacteria was the one that presented the
greatest ability to form biofilm and co-aggregate with all tested
pathogens, especially C. albicans. We highlight that all lactobacilli
tested only inhibited C. albicans in the displacement assay, thus
suggesting a potential for treating vaginal infections caused by
C. albicans.
Several parameters are considered in order to attribute
probiotic properties to a microorganism. Criteria include (i)
ability to adhere to host epithelial cells and mucus, (ii)
biofilm production, (iii) capability to co-aggregate with bacterial
pathogens, (iv) inhibition of pathogen binding to mucus and
epithelial cells, and (v) antimicrobial activity (Andreu et al., 1995;
Mastromarino et al., 2002; Martin et al., 2008; Van Tassell and
Miller, 2011; Castro et al., 2013; Dhanani and Bagchi, 2013;
Nishiyama et al., 2013).
We observed distinct adhesion profiles for the lactobacilli
when tested with HeLa cells. This was expected as bacterial
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FIGURE 3 | Inhibition of mucin adhesion by exclusion. Effect of different lactobacilli on (A) C. albicans, (B) S. agalactiae, and (C) N. gonorrhoeae binding to
mucin. The values are expressed in CFU/ml and represent the means of the values obtained. For all experiments, the purity of the colonies was checked both
macroscopically (by the growth aspects) and microscopically (by the Gram stain). The assay was performed in triplicate. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
adhesion to cellular surfaces is multifactorial and involves
different specific and non-specific interactions between bacterial
and cell surface components. Non-specific mechanisms involve
electrostatic and hydrophobic interactions, whereas the specific
mechanisms are related to surface molecules, such as outer
membrane proteins (Frece et al., 2005; Chen et al., 2007; Johnson-
Henry et al., 2007; Zhang et al., 2013; Meng et al., 2014),
exopolysaccharides (EPSs, Lebeer et al., 2011), lipoteichoic acids
(Granato et al., 1999), peptidoglycans (Van Tassell and Miller,
2011), glycosaminoglycans (Martin et al., 2013), flagella, and
fimbriae (Singh et al., 2013). This complex scenario results in
species-specific adhesion (Deepika and Charalampopoulos, 2010;
Messaoudi et al., 2012; Verdenelli et al., 2014) and may be related
to the differences observed in the present study.
All the analyzed Lactobacillus species exhibited strong mucin
binding at levels even higher (1 log10 difference) than those
previously reported for other strains (Tallon et al., 2007). The
main component of cervical mucus is mucin, which functions
as a protective barrier against invasive pathogens in the uterus
and vagina. An ideal probiotic may exhibit increased binding
to mucus to facilitate its permanence and growth in the female
genital tract, similar to their binding in the gastrointestinal tract
(Perea Velez et al., 2007). Porcine intestinal mucin has been
widely used to identifying the bind capacity of a certain bacteria
to mucus (Tuomola et al., 1999; Izquierdo et al., 2008; Laparra
and Sanz, 2009). We found that L. acidophilus ATCC 4356 and
L. paracasei ATCC 335 poorly adhere to HeLa cells, although
they are able to bind to mucin, suggesting these lactobacilli
present mucin-specific surface lectins. On the other hand,
L. brevis ATCC 367, L. fermentum ATCC 23271, L. delbrueckii
ssp. delbrueckii ATCC 9645, L. plantarum ATCC 8014, and
L. rhamnosus ATCC 9595 were able to adhere to HeLa cells and
to bind to immobilized mucin, possibly due to their hydrophobic
surfaces and/or expression of some adhesins. Mucin binding
by probiotics is considered as a pre-requisite for creating a
protective barrier against pathogen adhesion to epithelial cells by
either occupying mucin-binding sites or producing antimicrobial
compounds (Messaoudi et al., 2012; Zhang et al., 2013). It is
possible that the greater the ability of Lactobacillus spp. to
bind to mucin, the greater their ability to impair pathogen
binding to the genital tract. It was previously described that
microorganisms with a hydrophobic cell wall harbor a large
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FIGURE 4 | Inhibition of mucin adhesion by displacement. Effect of different lactobacilli on (A) C. albicans, (B) S. agalactiae, and (C) N. gonorrhoeae binding to
mucin. The values are expressed in CFU/ml and represent the means of the values obtained. For all experiments, the purity of the colonies was checked both
macroscopically (by the growth aspects) and microscopically (by the Gram stain). The assay was performed in triplicate. ∗∗∗p < 0.001.
variety of surface glycoproteins, increasing the probability of
adhesion to cellular receptors (Kos et al., 2003) or to cell wall-
anchored proteins (Polak-Berecka et al., 2014; Zhang et al., 2015).
Indeed, adhesion-promoting proteins that are involved in the
binding of distinct Lactobacillus species to mucin have been
previously identified, including a mucin adhesion-promoting
protein (MAPP) in L. fermentum strain 104R (Rojas et al., 2002),
the elongation factor Tu in L. johnsonii strain La1 (Granato et al.,
2004), and a fibronectin-binding protein (FbpB) in L. acidophilus
strain NCFM (Hymes et al., 2016).
Interaction with mucin allows the lactobacilli to remain within
the mucus layers, thereby contributing to the formation of multi-
species biofilms (Wickstrom et al., 2013), which are essential for
protection against intruding pathogens (Pi et al., 2011). Amongst
the tested Lactobacillus species, L. fermentum ATCC 23271
was the only to produce moderate biofilm on plastic surface
in comparison with other lactobacilli. Biofilm formation by
Lactobacillus species is influenced by many variables, including
the culture medium, the concentration of the inoculum, the
tested strain, and even the chemical nature of the support used for
the assay (Terraf et al., 2012). All tested genital pathogens adhered
to mucin at the same level as the lactobacilli (>105 CFU/ml).
It is possible that in order to establish a genital infection, a
successful pathogen has to overcome Lactobacillus colonization
thus promoting host cell adherence and/or invasion. To test
this hypothesis, we performed two competitive binding assays
to mucin, exclusion (Lactobacillus added and then, pathogen)
and displacement (pathogen added and then, Lactobacillus).
Interestingly, the exclusion assay indicated lactobacilli enhance
pathogen adherence to mucin. A previous study reported that
some lactobacilli isolated from the vaginal tract enhance the
adherence of C. albicans and Actinomyces neuii to human
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TABLE 2 | Co-aggregation scores for Lactobacillus spp. and genital
pathogens.
Lactobacillus
species
Aggregation score∗
C. albicans S. agalactiae N. gonorrhoeae
L. acidophilus 2 1 1
L. brevis 3 1 4
L. delbrueckii ssp.
delbrueckii
1 1 1
L. fermentum 4 3 3
L. paracasei 1 4 3
L. plantarum 3 1 2
L. rhamnosus 3 1 1
∗Mean co-aggregation scores of triplicate experiments. The microbial suspensions
were evaluated and a score was attributed as follows: 0 = no aggregation,
1 = small aggregates comprising small visible clusters of bacteria, 2 = aggregates
comprising larger numbers of bacteria, settling to the center of the well,
3 = macroscopically visible clumps comprising larger groups of bacteria which
settle to the center of the well, 4 = maximum score allocated to describe a large,
macroscopically visible clump in the center of the well. Aggregates were visualized
under inverted light microscopy and results are expressed as aggregation score.
TABLE 3 | Growth inhibition zones of genital pathogens produced by
Lactobacillus strains.
Lactobacillus Inhibition zone (mm)∗
C. albicans S. agalactiae N. gonorrhoeae
L. acidophilus 15 16.3 ± 0.4 14.6 ± 0.4
L. brevis 13 ± 0.8 17.3 ± 0.4 19.3 ± 1.2
L. delbrueckii ssp.
delbrueckii∗∗
– – –
L. fermentum 13 ± 0.8 14.3 ± 1.2 9 ± 0.8
L. paracasei 14 14.6 ± 0.4 13.6 ± 0.4
L. plantarum 14 ± 1.4 19.6 ± 0.4 17.3 ± 2.0
L. rhamnosus∗∗∗ – 15.3 ± 1.2 15
∗Values represent the mean (mm) ± standard deviation (SD) of triplicate samples
performed on three separate days. ∗∗Dashes (–) indicate that L. delbrueckii ssp.
delbrueckii inhibited C. albicans, S. agalactiae, and N. gonorrhoeae growth only
in the area above Lactobacillus growth without formation of an inhibition zone.
∗∗∗Dashes (–) indicate that L. rhamnosus inhibited C. albicans growth only in the
area above Lactobacillus growth without formation of an inhibition zone.
epithelial cells in vitro (Martin et al., 2012). The same study
suggested that secretion of aggregation proteins by lactobacilli
might favor a positive interaction of pathogens within host cells.
Additional studies have suggested that expression of EPSs may
enhance the interaction of pathogens with host cells (Marcotte
et al., 2004; Ruas-Madiedo et al., 2006; Macias-Rodriguez
et al., 2009). Apparently, this increased adhesion of pathogens
might be explained by the increased binding of pathogens to
specific EPSs, which in turn, enhanced adherence to mucus
(Ruas-Madiedo et al., 2006). Although these events have been
observed for enteropathogens, they may also occur for genital
pathogens.
On the other hand, all lactobacilli inhibited the adhesion
of C. albicans in the displacement assay, suggesting they
could potentially be used to complement the treatment of
TABLE 4 | Antimicrobial activity of L. fermentum ATCC 23270 against
clinical isolates of Candida spp.
Candida species
(number of strains)
Strain
designation
Inhibitory activity
(inhibition zone in mm)∗
C. albicans (2) VLAG + (18 ± 0.1)
MRSM + (WZ)
C. glabrata (2) FC 50 + (WZ)
CMLS + (WZ)
C. parapsilosis (1) RCL + (WZ)
C. tropicalis (1) RRL + (WZ)
C. krusei (1) GSFO –
∗This value is the mean (mm) ± standard deviations of triplicate samples performed
on three separate days; + denotes presence of inhibitory activity; WZ denotes
that the growth was inhibited, but without zone formation; – denotes absence of
inhibitory activity.
infections caused by this pathogen, at least as adjuvants.
C. albicans displacement may be attributed to the production of
antimicrobial substances by the lactobacilli, as supported by the
antimicrobial activity assay. Furthermore, Lactobacillus species
exhibited inhibitory effects against yeasts at low concentrations
(105 CFU/ml). This finding may be of clinical relevance for
probiotic therapy in immunocompromised patients in whom
high concentrations of these microorganisms can trigger clinical
complications (Kirjavainen et al., 1999; Apostolou et al., 2001;
Ren et al., 2012). None of the tested lactobacilli affected
either S. agalactiae or N. gonorrhoeae in the displacement
assay. It is possible that these bacteria express proteins (or
other components) that bind with high affinity to mucin, and
consequently, this has hindered the displacement effect for
the lactobacilli analyzed. In fact, adhesins involved in host
cell colonization and in the interaction to host extracellular
components have been described for both pathogens (Edwards
and Apicella, 2004; Lalioui et al., 2005).
In the present study, lactobacilli presented with different co-
aggregation activities. L. fermentum co-aggregated most strongly
with the genital pathogens C. albicans, N. gonorrhoeae, and
S. agalactiae. In agreement with previous studies, Lactobacillus
species, including L. acidophilus, L. gasseri, amongst others,
exhibit different co-aggregation activities with the same
pathogens, suggesting a species-specific process (Boris et al.,
1998; Osset et al., 2001). The formation of co-aggregates
has been suggested as a key event for the elimination of
pathogens as this close interaction allows the lactobacilli to
create an adverse microenvironment for pathogens by delivering
antimicrobial substances in a localized manner, and thus,
impairing epithelial colonization (Mastromarino et al., 2002;
Younes et al., 2012). Herein, all tested Lactobacillus strains
were inhibitory against the tested genital pathogens. This is in
agreement with previous reports showing that Lactobacillus
species, including those assessed in our study, are able to produce
antibacterial metabolites, such as bacteriocins (Todorov et al.,
2011), biosurfactants, organic acids, and H2O2 (Verdenelli et al.,
2014); which can act in synergy, reducing pathogen survival.
The probiotic properties of L. fermentum ATCC 23271
observed for the reference strain of C. albicans as well as the
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growth inhibition of Candida clinical isolates suggest that it is
possible this Lactobacillus may be useful for the treatment or
prophylaxis of vaginal candidiasis. Interestingly, L. fermentum
inhibited the growth of two of the most relevant Candida
species involved in vaginal candidiasis: C. albicans, which can
be found in 80–90% of cases and C. glabrata, which is the
second most common species, being responsible for 5–15%
of the vaginal candidiasis cases (Ferrer, 2000; Sobel, 2007).
Indeed, L. fermentum has been previously shown to inhibit
pathogen growth. In a recent study, the growth and virulence
of Escherichia coli and Gardnerella vaginalis were inhibited
by the L. fermentum strain SK5 (Kaewnopparat et al., 2013).
Similar effects were observed for the L. fermentum strain Ess-1,
which was shown to inhibit C. albicans and C. glabrata growth
(Rönnqvist et al., 2007) and for L. fermentum HV6b MTCC
10770, which was able to reduce the growth of Bacteroides,
G. vaginalis, Mobiluncus, Staphylococcus spp., and Streptococcus
spp L. fermentum antimicrobial actions have been attributed
to its ability to produce a bacteriocin-like compound (Sabia
et al., 2014) and to secrete the antimicrobial peptide fermenticin
HV6b (Kaur et al., 2013). Additionally, Pascual et al. (2010)
demonstrated that L. fermentum L23 presents in vivo probiotic
actions against vaginitis by treating and preventing E. coli-
induced infections.
Collectively, our data show for the first time that L. fermentum
ATCC 23271 is a prominent probiotic, exhibiting the highest
levels of adhesion to HeLa cells and binding to mucin, in addition
to antimicrobial properties against pathogens of importance
to female genital tract infections, particularly against Candida
spp. Herein, L. fermentum presented with the best probiotic
profile in comparison with the other tested lactobacilli species.
Finally, we suggest that L. fermentum could be used alone or
in combination with other species in order to treat genital
infections.
AUTHOR CONTRIBUTIONS
MC designed and performed the experiments, contributed to
data interpretation, manuscript writing, and approval of the final
version for publication; FN, MA, EdS, and MB performed the
experiments, contributed to data interpretation, and approval
of the final version for publications; AM and TF contributed
to data interpretation and revised the manuscript; EF and JG
contributed to data interpretation, revised the manuscript, and
approved the final version for publication; VM-N conceived the
study, participated in its design and coordination, and critically
revised the manuscript.
FUNDING
This study was supported by the Foundation for Research
Support and to Scientific and Technological Development of
Maranhão (FAPEMA, grant award 01041/13) and by the National
Council for Scientific and Technological Development (CNPq,
grant award 482037).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2016.01722/full#supplementary-material
REFERENCES
Alexandre, Y., Le Berre, R., Barbier, G., and Le Blay, G. (2014). Screening of
Lactobacillus spp. for the prevention of Pseudomonas aeruginosa pulmonary
infections. BMC Microbiol. 14:107. doi: 10.1186/1471-2180-14-107
Andreu, A., Stapleton, A. E., Fennell, C. L., Hillier, S. L., and Stamm, W. E. (1995).
Hemagglutination, adherence, and surface properties of vaginal Lactobacillus
species. J. Infect. Dis. 171, 1237–1243. doi: 10.1093/infdis/171.5.1237
Antonio, M. A., Meyn, L. A., Murray, P. J., Busse, B., and Hillier, S. L. (2009).
Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased
by sexual activity and endogenous Lactobacilli. J. Infect. Dis. 199, 1506–1513.
doi: 10.1086/598686
Apostolou, E., Kirjavainen, P. V., Saxelin, M., Rautelin, H., Valtonen, V., Salminen,
S. J., et al. (2001). Good adhesion properties of probiotics: a potential risk for
bacteremia? FEMS Immunol. Med. Microbiol. 31, 35–39. doi: 10.1111/j.1574-
695X.2001.tb01583.x
Boris, S., Suarez, J. E., Vazquez, F., and Barbes, C. (1998). Adherence of human
vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens.
Infect. Immun. 66, 1985–1989.
Castro, J., Henriques, A., Machado, A., Henriques, M., Jefferson, K. K., and
Cerca, N. (2013). Reciprocal interference between Lactobacillus spp. and
Gardnerella vaginalis on initial adherence to epithelial cells. Int. J. Med. Sci. 10,
1193–1198. doi: 10.7150/ijms.6304
Chen, X., Xu, J., Shuai, J., Chen, J., Zhang, Z., and Fang, W. (2007). The S-layer
proteins of Lactobacillus crispatus strain ZJ001 is responsible for competitive
exclusion against Escherichia coli O157:H7 and Salmonella typhimurium. Int. J.
Food Microbiol. 115, 307–312. doi: 10.1016/j.ijfoodmicro.2006.11.007
Deepika, G., and Charalampopoulos, D. (2010). Surface and adhesion properties
of lactobacilli. Adv. Appl. Microbiol. 70, 127–152. doi: 10.1016/S0065-
2164(10)70004-6
Dhanani, A. S., and Bagchi, T. (2013). The expression of adhesin EF-Tu in
response to mucin and its role in Lactobacillus adhesion and competitive
inhibition of enteropathogens to mucin. J. Appl. Microbiol. 115, 546–554. doi:
10.1111/jam.12249
Donders, G. G., Vereecken, A., Bosmans, E., Dekeersmaecker, A., Salembier, G.,
and Spitz, B. (2002). Definition of a type of abnormal vaginal flora that is
distinct from bacterial vaginosis: aerobic vaginitis. BJOG 109, 34–43. doi:
10.1111/j.1471-0528.2002.00432.x
Edwards, J. L., and Apicella, M. A. (2004). The molecular mechanisms used by
Neisseria gonorrhoeae to initiate infection differ between men and women. Clin.
Microbiol. Rev. 17, 965–981. doi: 10.1128/CMR.17.4.965-981.2004
Ferrer, J. (2000). Vaginal candidosis: epidemiological and etiological factors. Int. J.
Gynaecol. Obstet. 71(Suppl. 1), S21–S27. doi: 10.1016/S0020-7292(00)00350-7
Ferris, M. J., Norori, J., Zozaya-Hinchliffe, M., and Martin, D. H. (2007).
Cultivation-independent analysis of changes in bacterial vaginosis flora
following metronidazole treatment. J. Clin. Microbiol. 45, 1016–1018. doi:
10.1128/JCM.02085-06
Frece, J., Kos, B., Svetec, I. K., Zgaga, Z., Mrsa, V., and Suskovic, J. (2005).
Importance of S-layer proteins in probiotic activity of Lactobacillus acidophilus
M92. J. Appl. Microbiol. 98, 285–292. doi: 10.1111/j.1365-2672.2004.02473.x
Gorska, S., Buda, B., Brzozowska, E., Schwarzer, M., Srutkova, D., Kozakova, H.,
et al. (2016). Identification of Lactobacillus proteins with different recognition
patterns between immune rabbit sera and nonimmune mice or human sera.
BMC Microbiol. 16:17. doi: 10.1186/s12866-016-0631-9
Frontiers in Microbiology | www.frontiersin.org 9 October 2016 | Volume 7 | Article 1722
fmicb-07-01722 October 27, 2016 Time: 17:13 # 10
do Carmo et al. Lactobacillus fermentum Inhibits Candida spp.
Granato, D., Bergonzelli, G. E., Pridmore, R. D., Marvin, L., Rouvet, M.,
and Corthesy-Theulaz, I. E. (2004). Cell surface-associated elongation factor
Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to
human intestinal cells and mucins. Infect. Immun. 72, 2160–2169. doi:
10.1128/IAI.72.4.2160-2169.2004
Granato, D., Perotti, F., Masserey, I., Rouvet, M., Golliard, M., Servin, A., et al.
(1999). Cell surface-associated lipoteichoic acid acts as an adhesion factor for
attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2
cells. Appl. Environ. Microbiol. 65, 1071–1077.
Hansen, S. M., Uldbjerg, N., Kilian, M., and Sorensen, U. B. (2004). Dynamics of
Streptococcus agalactiae colonization in women during and after pregnancy and
in their infants. J. Clin. Microbiol. 42, 83–89. doi: 10.1128/JCM.42.1.83-89.2004
Hymes, J. P., Johnson, B. R., Barrangou, R., and Klaenhammer, T. R. (2016).
Functional analysis of an S-layer associated fibronectin-binding protein in
Lactobacillus acidophilus NCFM. Appl. Environ. Microbiol. 82, 2676–2685. doi:
10.1128/AEM.00024-16
Izquierdo, E., Medina, M., Ennahar, S., Marchioni, E., and Sanz, Y. (2008).
Resistance to simulated gastrointestinal conditions and adhesion to mucus
as probiotic criteria for Bifidobacterium longum strains. Curr. Microbiol. 56,
613–618. doi: 10.1007/s00284-008-9135-7
Johnson-Henry, K. C., Hagen, K. E., Gordonpour, M., Tompkins, T. A.,
and Sherman, P. M. (2007). Surface-layer protein extracts from
Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli
O157:H7 adhesion to epithelial cells. Cell Microbiol. 9, 356–367. doi:
10.1111/j.1462-5822.2006.00791.x
Kaewnopparat, S., Dangmanee, N., Kaewnopparat, N., Srichana, T., Chulasiri, M.,
and Settharaksa, S. (2013). In vitro probiotic properties of Lactobacillus
fermentum SK5 isolated from vagina of a healthy woman. Anaerobe 22, 6–13.
doi: 10.1016/j.anaerobe.2013.04.009
Kaur, B., Balgir, P. P., Mittu, B., Kumar, B., and Garg, N. (2013). Biomedical
applications of fermenticin HV6b isolated from Lactobacillus fermentum HV6b
MTCC10770. Biomed. Res. Int. 2013:168438. doi: 10.1155/2013/168438
Kirjavainen, P. V., Tuomola, E. M., Crittenden, R. G., Ouwehand, A. C., Harty,
D. W., Morris, L. F., et al. (1999). In vitro adhesion and platelet aggregation
properties of bacteremia-associated lactobacilli. Infect. Immun. 67, 2653–2655.
Kos, B., Suskovic, J., Vukovic, S., Simpraga, M., Frece, J., and Matosic, S.
(2003). Adhesion and aggregation ability of probiotic strain Lactobacillus
acidophilus M92. J. Appl. Microbiol. 94, 981–987. doi: 10.1046/j.1365-2672.2003.
01915.x
Lalioui, L., Pellegrini, E., Dramsi, S., Baptista, M., Bourgeois, N., Doucet-
Populaire, F., et al. (2005). The SrtA Sortase of Streptococcus agalactiae is
required for cell wall anchoring of proteins containing the LPXTG motif, for
adhesion to epithelial cells, and for colonization of the mouse intestine. Infect.
Immun. 73, 3342–3350. doi: 10.1128/IAI.73.6.3342-3350.2005
Laparra, J. M., and Sanz, Y. (2009). Comparison of in vitro models to study bacterial
adhesion to the intestinal epithelium. Lett. Appl. Microbiol. 49, 695–701. doi:
10.1111/j.1472-765X.2009.02729.x
Lebeer, S., Claes, I. J., Verhoeven, T. L., Vanderleyden, J., and De Keersmaecker,
S. C. (2011). Exopolysaccharides of Lactobacillus rhamnosus GG form a
protective shield against innate immune factors in the intestine. Microb.
Biotechnol. 4, 368–374. doi: 10.1111/j.1751-7915.2010.00199.x
Li, J., McCormick, J., Bocking, A., and Reid, G. (2012). Importance of
vaginal microbes in reproductive health. Reprod. Sci. 19, 235–242. doi:
10.1177/1933719111418379
Lidbeck, A., and Nord, C. E. (1993). Lactobacilli and the normal human
anaerobic microflora. Clin. Infect. Dis. 16(Suppl. 4), S181–S187. doi:
10.1093/clinids/16.Supplement_4.S181
Lobos, O., Padilla, A., and Padilla, C. (2013). [Genetic analysis and virulent
properties of Escherichia coli strains isolated from vaginal infection]. Rev.
Chilena Infectol. 30, 381–387. doi: 10.4067/S0716-10182013000400005
Macias-Rodriguez, M. E., Zagorec, M., Ascencio, F., Vazquez-Juarez, R., and
Rojas, M. (2009). Lactobacillus fermentum BCS87 expresses mucus- and mucin-
binding proteins on the cell surface. J. Appl. Microbiol. 107, 1866–1874. doi:
10.1111/j.1365-2672.2009.04368.x
Marcotte, H., Ferrari, S., Cesena, C., Hammarstrom, L., Morelli, L., Pozzi, G.,
et al. (2004). The aggregation-promoting factor of Lactobacillus crispatus M247
and its genetic locus. J. Appl. Microbiol. 97, 749–756. doi: 10.1111/j.1365-
2672.2004.02364.x
Martin, R., Martin, C., Escobedo, S., Suarez, J. E., and Quiros, L. M. (2013). Surface
glycosaminoglycans mediate adherence between HeLa cells and Lactobacillus
salivarius Lv72. BMC Microbiol. 13:210. doi: 10.1186/1471-2180-13-210
Martin, R., Sanchez, B., Suarez, J. E., and Urdaci, M. C. (2012). Characterization
of the adherence properties of human Lactobacilli strains to be used as
vaginal probiotics. FEMS Microbiol. Lett. 328, 166–173. doi: 10.1111/j.1574-
6968.2011.02495.x
Martin, R., Soberon, N., Vazquez, F., and Suarez, J. E. (2008). [Vaginal microbiota:
composition, protective role, associated pathologies, and therapeutic
perspectives]. Enferm. Infecc. Microbiol. Clin. 26, 160–167.
Mastromarino, P., Brigidi, P., Macchia, S., Maggi, L., Pirovano, F., Trinchieri, V.,
et al. (2002). Characterization and selection of vaginal Lactobacillus strains
for the preparation of vaginal tablets. J. Appl. Microbiol. 93, 884–893. doi:
10.1046/j.1365-2672.2002.01759.x
Medellin-Pena, M. J., and Griffiths, M. W. (2009). Effect of molecules secreted by
Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization.
Appl. Environ. Microbiol. 75, 1165–1172. doi: 10.1128/AEM.01651-08
Meng, J., Zhu, X., Gao, S. M., Zhang, Q. X., Sun, Z., and Lu, R. R. (2014).
Characterization of surface layer proteins and its role in probiotic properties
of three Lactobacillus strains. Int. J. Biol. Macromol. 65, 110–114. doi:
10.1016/j.ijbiomac.2014.01.024
Messaoudi, S., Madi, A., Prevost, H., Feuilloley, M., Manai, M., Dousset, X., et al.
(2012). In vitro evaluation of the probiotic potential of Lactobacillus salivarius
SMXD51. Anaerobe 18, 584–589. doi: 10.1016/j.anaerobe.2012.10.004
Nami, Y., Abdullah, N., Haghshenas, B., Radiah, D., Rosli, R., and Khosroushahi,
A. Y. (2014). Probiotic potential and biotherapeutic effects of newly isolated
vaginal Lactobacillus acidophilus 36YL strain on cancer cells. Anaerobe 28,
29–36. doi: 10.1016/j.anaerobe.2014.04.012
Nishiyama, K., Ochiai, A., Tsubokawa, D., Ishihara, K., Yamamoto, Y., and
Mukai, T. (2013). Identification and characterization of sulfated carbohydrate-
binding protein from Lactobacillus reuteri. PLoS ONE 8:e83703. doi:
10.1371/journal.pone.0083703
Osset, J., Garcia, E., Bartolome, R. M., and Andreu, A. (2001). [Role of Lactobacillus
as protector against vaginal candidiasis]. Med. Clin. (Barc) 117, 285–288. doi:
10.1016/S0025-7753(01)72089-1
Pascual, L., Ruiz, F., Giordano, W., and Barberis, I. L. (2010). Vaginal colonization
and activity of the probiotic bacterium Lactobacillus fermentum L23 in a
murine model of vaginal tract infection. J. Med. Microbiol. 59, 360–364. doi:
10.1099/jmm.0.012583-0
Perea Velez, M., Hermans, K., Verhoeven, T. L., Lebeer, S. E., Vanderleyden, J.,
and De Keersmaecker, S. C. (2007). Identification and characterization
of starter lactic acid bacteria and probiotics from Columbian dairy
products. J. Appl. Microbiol. 103, 666–674. doi: 10.1111/j.1365-2672.2007.
03294.x
Pi, W., Ryu, J. S., and Roh, J. (2011). Lactobacillus acidophilus contributes to a
healthy environment for vaginal epithelial cells. Korean J. Parasitol. 49, 295–298.
doi: 10.3347/kjp.2011.49.3.295
Polak-Berecka, M., Wasko, A., Paduch, R., Skrzypek, T., and Sroka-Bartnicka, A.
(2014). The effect of cell surface components on adhesion ability of
Lactobacillus rhamnosus. Antonie Van Leeuwenhoek 106, 751–762. doi:
10.1007/s10482-014-0245-x
Puopolo, K. M., Madoff, L. C., and Eichenwald, E. C. (2005). Early-onset group
B streptococcal disease in the era of maternal screening. Pediatrics 115, 1240–
1246. doi: 10.1542/peds.2004-2275
Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S., McCulle, S. L., et al.
(2011). Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci.
U.S.A. 108(Suppl. 1), 4680–4687. doi: 10.1073/pnas.1002611107
Reid, G., McGroarty, J. A., Domingue, P. G., Chow, A. W., Bruce, A. W., Eisen, A.,
et al. (1990). Coaggregation of urogenital bacteria in vitro and in vivo. Curr.
Microbiol. 20, 47–52. doi: 10.1007/BF02094024
Ren, D., Li, C., Qin, Y., Yin, R., Li, X., Tian, M., et al. (2012). Inhibition
of Staphylococcus aureus adherence to Caco-2 cells by lactobacilli and cell
surface properties that influence attachment. Anaerobe 18, 508–515. doi:
10.1016/j.anaerobe.2012.08.001
Rojas, M., Ascencio, F., and Conway, P. L. (2002). Purification and characterization
of a surface protein from Lactobacillus fermentum 104R that binds to porcine
small intestinal mucus and gastric mucin. Appl. Environ. Microbiol. 68, 2330–
2336. doi: 10.1128/AEM.68.5.2330-2336.2002
Frontiers in Microbiology | www.frontiersin.org 10 October 2016 | Volume 7 | Article 1722
fmicb-07-01722 October 27, 2016 Time: 17:13 # 11
do Carmo et al. Lactobacillus fermentum Inhibits Candida spp.
Rönnqvist, D., Forsgren-Brusk, U., Husmark, U., and Grahn-Håkansson, E.
(2007). Lactobacillus fermentum Ess-1 with unique growth inhibition of
vulvo-vaginal candidiasis pathogens. J. Med. Microbiol. 56, 1500–1504. doi:
10.1099/jmm.0.47226-0
Ruas-Madiedo, P., Gueimonde, M., Margolles, A., de los Reyes-Gavilan, C. G., and
Salminen, S. (2006). Exopolysaccharides produced by probiotic strains modify
the adhesion of probiotics and enteropathogens to human intestinal mucus.
J. Food Prot. 69, 2011–2015.
Sabia, C., Anacarso, I., Bergonzini, A., Gargiulo, R., Sarti, M., Condò, C., et al.
(2014). Detection and partial characterization of a bacteriocin-like substance
produced by Lactobacillus fermentum CS57 isolated from human vaginal
secretions. Anaerobe 26, 41–45. doi: 10.1016/j.anaerobe.2014.01.004
Singh, D., von Ossowski, I., Palva, A., and Krishnan, V. (2013). Purification,
crystallization and preliminary crystallographic analysis of the SpaA
backbone-pilin subunit from probiotic Lactobacillus rhamnosus GG. Acta
Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 69(Pt 10), 1182–1185. doi:
10.1107/S1744309113024676
Sobel, J. D. (2007). Vulvovaginal candidosis. Lancet 369, 1961–1971. doi:
10.1016/S0140-6736(07)60917-9
Spurbeck, R. R., and Arvidson, C. G. (2010). Lactobacillus jensenii surface-
associated proteins inhibit Neisseria gonorrhoeae adherence to epithelial cells.
Infect. Immun. 78, 3103–3111. doi: 10.1128/IAI.01200-09
Stepanovic, S., Vukovic, D., Dakic, I., Savic, B., and Svabic-Vlahovic, M.
(2000). A modified microtiter-plate test for quantification of staphylococcal
biofilm formation. J. Microbiol. Methods 40, 175–179. doi: 10.1016/S0167-
7012(00)00122-6
Tallon, R., Arias, S., Bressollier, P., and Urdaci, M. (2007). Strain-and matrix-
dependent adhesion of Lactobacillus plantarum is mediated by proteinaceous
bacterial compounds. J. Appl. Microbiol. 102, 442–451. doi: 10.1111/j.1365-
2672.2006.03086.x
Terraf, M. C., Juarez Tomas, M. S., Nader-Macias, M. E., and Silva, C. (2012).
Screening of biofilm formation by beneficial vaginal lactobacilli and influence
of culture media components. J. Appl. Microbiol. 113, 1517–1529. doi:
10.1111/j.1365-2672.2012.05429.x
Todorov, S. D., Furtado, D. N., Saad, S. M., and Gombossy de Melo Franco,
B. D. (2011). Bacteriocin production and resistance to drugs are advantageous
features for Lactobacillus acidophilus La-14, a potential probiotic strain. New
Microbiol. 34, 357–370.
Tuomola, E., Ouwehand, A., and Salminen, S. (1999). Human ileostomy
glycoproteins as a model for small intestinal mucus to investigate adhesion
of probiotics. Lett. Appl. Microbiol. 28, 159–163. doi: 10.1046/j.1365-
2672.1999.00518.x
Van Tassell, M. L., and Miller, M. J. (2011). Lactobacillus adhesion to mucus.
Nutrients 3, 613–636. doi: 10.3390/nu3050613
Verdenelli, M. C., Coman, M. M., Cecchini, C., Silvi, S., Orpianesi, C., and
Cresci, A. (2014). Evaluation of antipathogenic activity and adherence
properties of human Lactobacillus strains for vaginal formulations. J. Appl.
Microbiol. 116, 1297–1307. doi: 10.1111/jam.12459
Walencka, E., Rozalska, S., Sadowska, B., and Rozalska, B. (2008). The influence
of Lactobacillus acidophilus-derived surfactants on staphylococcal adhesion and
biofilm formation. Folia Microbiol. (Praha) 53, 61–66. doi: 10.1007/s12223-008-
0009-y
Wang, Z. L., Fu, L. Y., Xiong, Z. A., Qin, Q., Yu, T. H., Wu, Y. T., et al.
(2016). Diagnosis and microecological characteristics of aerobic vaginitis in
outpatients based on preformed enzymes. Taiwan J Obstet Gynecol 55, 40–44.
doi: 10.1016/j.tjog.2015.06.012
WHO (2012). Global incidence and prevalence of selected curable sexually
transmitted infections – 2008. Geneva: World Health Organization.
Wickstrom, C., Chavez de Paz, L., Davies, J. R., and Svensater, G. (2013).
Surface-associated MUC5B mucins promote protease activity in Lactobacillus
fermentum biofilms. BMC Oral Health 13:43. doi: 10.1186/1472-6831-13-43
Witkin, S. S., Linhares, I. M., and Giraldo, P. (2007). Bacterial flora of the female
genital tract: function and immune regulation. Best Pract. Res. Clin. Obstet.
Gynaecol. 21, 347–354. doi: 10.1016/j.bpobgyn.2006.12.004
Younes, J. A., van der Mei, H. C., van den Heuvel, E., Busscher, H. J.,
and Reid, G. (2012). Adhesion forces and coaggregation between vaginal
staphylococci and lactobacilli. PLoS ONE 7:e36917. doi: 10.1371/journal.pone.
0036917
Zabihollahi, R., Motevaseli, E., Sadat, S. M., Azizi-Saraji, A. R., Asaadi-Dalaie, S.,
and Modarressi, M. H. (2012). Inhibition of HIV and HSV infection by
vaginal lactobacilli in vitro and in vivo. Daru 20:53. doi: 10.1186/2008-2231-
20-53
Zhang, B., Zuo, F., Yu, R., Zeng, Z., Ma, H., and Chen, S. (2015). Comparative
genome-based identification of a cell wall-anchored protein from Lactobacillus
plantarum increases adhesion of Lactococcus lactis to human epithelial cells. Sci.
Rep. 5:14109. doi: 10.1038/srep14109
Zhang, R., Daroczy, K., Xiao, B., Yu, L., Chen, R., and Liao, Q. (2012). Qualitative
and semiquantitative analysis of Lactobacillus species in the vaginas of healthy
fertile and postmenopausal Chinese women. J. Med. Microbiol. 61(Pt 5), 729–
739. doi: 10.1099/jmm.0.038687-0
Zhang, W., Wang, H., Liu, J., Zhao, Y., Gao, K., and Zhang, J. (2013). Adhesive
ability means inhibition activities for Lactobacillus against pathogens and
S-layer protein plays an important role in adhesion. Anaerobe 22, 97–103. doi:
10.1016/j.anaerobe.2013.06.005
Zhou, X., Brown, C. J., Abdo, Z., Davis, C. C., Hansmann, M. A., Joyce, P.,
et al. (2007). Differences in the composition of vaginal microbial communities
found in healthy Caucasian and black women. ISME J. 1, 121–133. doi:
10.1038/ismej.2007.12
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Carmo, Noronha, Arruda, Costa, Bomfim, Monteiro, Ferro,
Fernandes, Girón and Monteiro-Neto. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 11 October 2016 | Volume 7 | Article 1722
